BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 33205689)

  • 1. Mucoadhesive gastroretentive microparticulate system for programmed delivery of famotidine and clarithromycin.
    Srivastava A; Verma A; Saraf S; Jain A; Tiwari A; Panda PK; Jain SK
    J Microencapsul; 2021 May; 38(3):151-163. PubMed ID: 33205689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.
    Rajinikanth PS; Karunagaran LN; Balasubramaniam J; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1658-64. PubMed ID: 19043235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based mucoadhesive microspheres of clarithromycin as a delivery system for antibiotic to stomach.
    Majithiya RJ; Murthy RS
    Curr Drug Deliv; 2005 Jul; 2(3):235-42. PubMed ID: 16305425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
    Adebisi AO; Conway BR
    Int J Pharm; 2014 Aug; 470(1-2):28-40. PubMed ID: 24792977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach.
    Ramachandran S; Shaheedha SM; Thirumurugan G; Dhanaraju MD
    Curr Drug Deliv; 2010 Jan; 7(1):93-7. PubMed ID: 20044907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK; Chavda JR
    J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized Mucoadhesive Coated Niosomes as a Sustained Oral Delivery System of Famotidine.
    Khalifa AM; Abdul Rasool BK
    AAPS PharmSciTech; 2017 Nov; 18(8):3064-3075. PubMed ID: 28516414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori.
    Jain SK; Jangdey MS
    Mol Pharm; 2009; 6(1):295-304. PubMed ID: 19093870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
    Patel JK; Patel MM
    Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.
    Dhaliwal S; Jain S; Singh HP; Tiwary AK
    AAPS J; 2008 Jun; 10(2):322-30. PubMed ID: 18523891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin- and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori.
    Ramteke S; Jain NK
    J Drug Target; 2008 Jan; 16(1):65-72. PubMed ID: 18172822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.
    Thombre NA; Gide PS
    Drug Deliv; 2016; 23(2):405-19. PubMed ID: 24870198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori.
    Chun MK; Sah H; Choi HK
    Int J Pharm; 2005 Jun; 297(1-2):172-9. PubMed ID: 15907604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and Evaluation of Propranolol Hydrochloride-Loaded Carbopol-934P/Ethyl Cellulose Mucoadhesive Microspheres.
    Patel J; Patel D; Raval J
    Iran J Pharm Res; 2010; 9(3):221-32. PubMed ID: 24363731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and Evaluation of Gastroretentive Ranitidine HCl Microspheres by Using Factorial Design with Improved Bioavailability and Mucosal Integrity in Ulcer Model.
    Khattab A; Zaki N
    AAPS PharmSciTech; 2017 May; 18(4):957-973. PubMed ID: 28271373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifunctional capsular dosage form: novel fanicular cylindrical gastroretentive system of clarithromycin and immediate release granules of ranitidine HCl for simultaneous delivery.
    Rajput P; Singh D; Pathak K
    Int J Pharm; 2014 Jan; 461(1-2):310-21. PubMed ID: 24309435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoadhesive microparticulate drug delivery system of curcumin against Helicobacter pylori infection: Design, development and optimization.
    Ali MS; Pandit V; Jain M; Dhar KL
    J Adv Pharm Technol Res; 2014 Jan; 5(1):48-56. PubMed ID: 24696817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
    Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
    Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori.
    Wang J; Tauchi Y; Deguchi Y; Morimoto K; Tabata Y; Ikada Y
    Drug Deliv; 2000; 7(4):237-43. PubMed ID: 11195431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.